These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9154287)

  • 1. The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation.
    Imesch PD; Wallow IH; Albert DM
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S117-23. PubMed ID: 9154287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphometric effects of long-term exposure to latanoprost.
    Cracknell KP; Grierson I; Hogg P
    Ophthalmology; 2007 May; 114(5):938-48. PubMed ID: 17292473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iris morphology.
    Teus MA; Arranz-Marquez E
    Ophthalmology; 2008 Feb; 115(2):418-9; author reply 419-20. PubMed ID: 18243921
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism and clinical significance of prostaglandin-induced iris pigmentation.
    Stjernschantz JW; Albert DM; Hu DN; Drago F; Wistrand PJ
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S162-75. PubMed ID: 12204714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color.
    Wistrand PJ; Stjernschantz J; Olsson K
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S129-38. PubMed ID: 9154289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue.
    Lindquist NG; Larsson BS; Stjernschantz J
    Exp Eye Res; 1999 Oct; 69(4):431-6. PubMed ID: 10504276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latanoprost and pigmentation.
    Grierson I; Jonsson M; Cracknell K
    Jpn J Ophthalmol; 2004; 48(6):602-12. PubMed ID: 15592791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of early change in iris color with latanoprost use.
    Pappas RM; Pusin S; Higginbotham EJ
    Arch Ophthalmol; 1998 Aug; 116(8):1115-6. PubMed ID: 9715697
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostaglandin-induced iridial pigmentation in primates.
    Selén G; Stjernschantz J; Resul B
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S125-8. PubMed ID: 9154288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fine structure of an iridectomy specimen from a patient with latanoprost-induced eye color change.
    Grierson I; Lee WR; Albert DM
    Arch Ophthalmol; 1999 Mar; 117(3):394-6. PubMed ID: 10088822
    [No Abstract]   [Full Text] [Related]  

  • 11. Histology and fine structure of the iris and outflow system following latanoprost therapy.
    Grierson I; Pfeiffer N; Cracknell KP; Appleton P
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S176-84. PubMed ID: 12204715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of irises with a latanoprost-induced change in iris color.
    Arranz-Marquez E; Teus MA; Saornil MA; Mendez MC; Gil R
    Am J Ophthalmol; 2004 Oct; 138(4):625-30. PubMed ID: 15488791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys.
    Prota G; Vincensi MR; Napolitano A; Selen G; Stjernschantz J
    Pigment Cell Res; 2000 Jun; 13(3):147-50. PubMed ID: 10885672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of iridial pigmentation between latanoprost and isopropyl unoprostone: a long term prospective comparative study.
    Chiba T; Kashiwagi K; Chiba N; Ishijima K; Furuichi M; Kogure S; Abe K; Tsukahara S
    Br J Ophthalmol; 2003 Aug; 87(8):956-9. PubMed ID: 12881333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monte Carlo simulation of latanoprost induced iris darkening.
    Cracknell KP; Farnell DJ; Grierson I
    Comput Methods Programs Biomed; 2007 Aug; 87(2):93-103. PubMed ID: 17576020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The iris after prostanoid treatment.
    Grierson I; Cracknell KP; Pfeiffer N
    Curr Opin Ophthalmol; 2001 Apr; 12(2):112-8. PubMed ID: 11224717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased iris pigment in a child due to latanoprost.
    Brown SM
    Arch Ophthalmol; 1998 Dec; 116(12):1683-4. PubMed ID: 9869807
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes.
    Chou SY; Chou CK; Kuang TM; Hsu WM
    Eye (Lond); 2005 Jul; 19(7):784-7. PubMed ID: 15359238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides.
    Albert DM; Gangnon RE; Grossniklaus HE; Green WR; Darjatmoko S; Kulkarni AD
    Arch Ophthalmol; 2008 May; 126(5):626-31. PubMed ID: 18474771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of a latanoprost-induced increase in iris pigmentation in Japanese eyes.
    Latanoprost-Induced Iris Pigmentation Study Group
    Jpn J Ophthalmol; 2006; 50(2):96-9. PubMed ID: 16604382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.